Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 988-994

  Oriente, Alfonso ^a   Fedarko, Neal S ^a   Pacocha, Sarah E ^a   Huang, Shau Ku ^a   Lichtenstein, Lawrence M ^a   Essayan, David M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGENASE; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; PROCOLLAGEN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL STIMULATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST CULTURE; FIBROSIS; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; KELOID; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; TISSUE REPAIR; WESTERN BLOTTING;

CELLS, CULTURED; COLLAGEN; FIBROBLASTS; HOMEOSTASIS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; MATRIX METALLOPROTEINASE 3; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034104598     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Abbas AK, Murphy KM and Sher A (1996) Functional diversity of helper T lymphocytes. Nature (Lond) 383:787-793.
2. Abildgaard N, Bendix-Hansen K, Kristensen JE, Vejlgaard T, Risteli L, Nielsen JL and Heickendorff L (1997) Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum. Br J Haematol 99:641-648.
3. Airola K, Johansson N, Kariniemi AL, Kahari VM and Saarialho-Kere UK (1997) Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 2:225-231.
4. 4 counter-regulation by CLA - memory T cells. J Immunol 159:4611-4619.
5. Cawston T (1998) Matrix metalloproteinases and TIMPs: Properties and implications for the rheumatic diseases. Mol Med Today 4:130-137.
6. Chesnutt AN, Matthay MA, Tibayan FA and Clark JG (1997) Early detection of type III procollagen peptide in acute lung injury: Pathogenetic and prognostic significance. Am J Respir Crit Care Med 156:840-845.
7. Chiaramonte MG, Donaldson DD, Cheever AW and Wynn TA (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104:777-785.
8. Coker RK and Laurent GJ (1998) Pulmonary fibrosis: Cytokines in the balance. Eur Respir J 11:1218-1221.
9. de Vries JE (1998) The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 102:165-169.
10. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW and Jasmin C (1998) Interleukin (IL) 4 and IL-13 act on human lung fibroblasts: Implication in asthma. J Clin Invest 101:2129-2139.
11. Duncan MR and Berman B (1991) Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 97:686-692.
12. Essayan DM, Han WF, Li XM, Xiao HQ, Kleine-Tebbe J and Huang S-K (1996) Clonal diversity of IL-4 and IL-13 expression in human allergen-specific T lymphocytes. J Allergy Clin Immunol 98:1035-1044.
13. Essayan DM, Krishnaswamy G and Huang S-K (1997) Immunologic investigations of T-cell regulation of human IgE antibody secretion and allergic responses. Methods 13:69-78.
14. Feng N, Lugli SM, Schnyder B, Gauchat JF, Graber P and Schlagenhauf E (1998) The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: Overexpression of the nonsignaling interleukin-13 receptor alpha2. Lab Invest 78:591-602.
15. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM and Corry DB (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science (Wash DC) 282: 2261-2263.
16. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M and Leung DY (1996) In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 98:225-231.
17. Hancock A, Armstrong L, Gama R and Millar A (1998) Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 18:60-65.
18. Hasegawa M, Fujimoto M, Kikuchi K and Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24:328-332.
19. Hatamochi A, Mori K and Ueki H (1994) Role of cytokines in controlling connective tissue gene expression. Arch Dermatol Res 287:115-121.
20. Huang S-K, Xiao HQ, Kleine-Tebbe J, Paciotti G, Marsh DG and Lichtenstein LM (1995) IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155:2688-2694.
21. Jimenez S, Hitraya E and Varga J (1996) Pathogenesis of scleroderma. Rheum Dis Clinics North Am 22:647-674.
22. Kim Y, Peyrol S, So CK, Boyd CD and Csiszar K (1999) Coexpression of lysil oxidase-like gene (LOXL) and the gene encoding type III procollagen in induced liver fibrosis. J Cell Biochem 72:181-188.
23. Kovacs E and DiPietro LA (1994) Fibrogenic cytokines and connective tissue production. FASEB J 8:854-861.
24. Kreis T and Vale R (1993) Guidebook to the Extracellular Matrix and Adhesion Molecules. Oxford University Press, New York.
25. Lammi L, Ryhanen L, Lakari E, Risteli J, Paakko P, Kahlos K, Lahde S and Kinnula V (1999) Type III and type I procollagen markers in fibrosing alveolitis. Am J Respir Crit Care Med 159:818-823.
26. Liu B and Connolly MK (1998) The pathogenesis of cutaneous fibrosis. Semin Cutan Med Surg 17:3-11.
27. Mauch C (1998) Regulation of connective tissue turnover by cell-matrix interactions. Arch Dermatol Res 290:30-36.
28. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P and Hamid Q (1997) Eosinophil-associated TGF-betal mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 17:326-333.
29. Murata T, Husain SR, Mohri H and Puri RK (1998) Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway. Int Immunol 10:1103-1110.
30. Mutsaers SE, Bishop JE, McGrouther G and Laurent GJ (1997) Mechanisms of tissue repair: From wound healing to fibrosis. Int J Biochem Cell Biol 29:5-17.
31. Postlethwaite AE (1995) Role of T cells and cytokines in effecting fibrosis. Int Rev Immunol 12:247-258.
32. Rankin JA, Picarella DE, Geba GP, Temann UA, Prasad B, DiCosmo B, Tarallo A, Stripp B, Whitsett J and Flavell RA (1996) Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: Lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 93:7821-7825.
33. Redrup AC, Howard BP, MacGlashan DW Jr, Kagey-Sobotka A, Lichtenstein LM and Schroeder JT (1998) Differential regulation of IL-4 and IL-13 secretion by human basophils: Their relationship to histamine release in mixed leukocyte cultures. J Immunol 160:1957-1964.
34. Roche WR, Beasley R, Williams JH and Holgate ST (1989) Subepithelial fibrosis in the bronchi of asthmatics. Lancet 8637:520-524.
35. Sime PJ, Marr RA, Gauldie D, Xing Z, Hewlett BR, Graham FL and Gauldie J (1998) Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-betal and myofibroblasta. Am J Pathol 153:825-832.
36. Sime PJ, Xing Z, Graham FL, Csaky KG and Gauldie J (1997) Adenovector-mediated gene transfer of active transforming growth factor-betal induces prolonged severe fibrosis in rat lung. J Clin Invest 100:768-776.
37. Tang W, Geba GP, Zheng T, Ray P, Homer RJ, Kuhn C, Flavell RA and Elias JA (1996) Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest 98: 2845-2853.
38. Van der Pouw Kraan TC, Van der Zee JS, Boeije LC, De Groot ER, Stapel SO and Arden LA (1998) The role of IL-13 in IgE synthesis by allergic asthma patients. Clin Exp Immunol 111:129-135.
39. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL and Donaldson DD (1998) Interleukin-13: Central mediator of allergic asthma. Science (Wash DC) 282:2258-2261.
40. Woessner JF (1961) The determination of hydroxyproline in tissue and protein samples containing small proportion of this amino acid. Arch Biochem Biophys 93:440-447.
41. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y and Elias JA (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103:779-788.